Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Incyte/MorphoSys Await EU Verdict On Tafasitamab For DLBCL
Updated Results From Monoclonal Antibody’s Phase II Trial Released In June
DLBCL is the most common type of non-Hodgkin lymphoma in adults • Source: Alamy
More from Europe
More from Geography